Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B.

Sakura Kirino,Nobuharu Tamaki,Masayuki Kurosaki,Shun Kaneko,Kento Inada,Yuki Tanaka,Shun Ishido,Koji Yamashita,Tsubasa Nobusawa,Hiroaki Matsumoto,Yuka Hayakawa,Tatsuya Kakegawa,Mayu Higuchi,Kenta Takaura,Shohei Tanaka,Chiaki Maeyashiki,Yutaka Yasui,Yuka Takahashi,Kaoru Tsuchiya,Hiroyuki Nakanishi,Ryuichi Okamoto,Namiki Izumi

Hepatology research : the official journal of the Japan Society of Hepatology（2023）

Cited 4|Views24
No score
Abstract
ALT <21 IU/L at 1 year after NA initiation has a lower risk of HCC and could be used as a target value for NA treatment.
More
Translated text
Key words
alanine aminotransferase,hepatitis B virus,hepatocellular carcinoma,nucleoside/nucleotide analog
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined